Diagnostic performances of Schistosoma haematobium and Schistosoma mansoni recombinant proteins, peptides and chimeric proteins antibody based tests. Systematic scoping review.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
09
2022
accepted:
11
02
2023
entrez:
2
3
2023
pubmed:
3
3
2023
medline:
7
3
2023
Statut:
epublish
Résumé
Traditional diagnostic tests for schistosome infections are suboptimal, particularly when the parasite burden is low. In the present review we sought to identify recombinant proteins, peptides, and chimeric proteins with potential to be used as sensitive and specific diagnostic tools for schistosomiasis. The review was guided by PRISMA-ScR guidelines, Arksey and O'Malley's framework, and guidelines from the Joanna Briggs Institute. Five databases were searched: Cochrane library, PubMed, EMBASE, PsycInfo and CINAHL, alongside preprints. Identified literature were assessed by two reviewers for inclusion. A narrative summary was used to interpret the tabulated results. Diagnostic performances were reported as specificities, sensitivities, and AUC. The AUC for S. haematobium recombinant antigens ranged from 0.65 to 0.98, and 0.69 to 0.96 for urine IgG ELISA. S. mansoni recombinant antigens had sensitivities ranging from 65.3% to 100% and specificities ranging from 57.4% to 100%. Except for 4 peptides which had poor diagnostic performances, most peptides had sensitivities ranging from 67.71% to 96.15% and specificities ranging from 69.23% to 100%. S. mansoni chimeric protein was reported to have a sensitivity of 86.8% and a specificity of 94.2%. The tetraspanin CD63 antigen had the best diagnostic performance for S. haematobium. The tetraspanin CD63 antigen Serum IgG POC-ICTs had a sensitivity of 89% and a specificity of 100%. Peptide Smp_150390.1 (216-230) serum based IgG ELISA had the best diagnostic performance for S. mansoni with a sensitivity of 96.15% and a specificity of 100%. Peptides were reported to demonstrate good to excellent diagnostic performances. S. mansoni multi-peptide chimeric protein further improved the diagnostic accuracy of synthetic peptides. Together with the advantages associated with urine sampling technique, we recommend development of multi-peptide chimeric proteins urine based point of care tools.
Sections du résumé
BACKGROUND
Traditional diagnostic tests for schistosome infections are suboptimal, particularly when the parasite burden is low. In the present review we sought to identify recombinant proteins, peptides, and chimeric proteins with potential to be used as sensitive and specific diagnostic tools for schistosomiasis.
METHODS
The review was guided by PRISMA-ScR guidelines, Arksey and O'Malley's framework, and guidelines from the Joanna Briggs Institute. Five databases were searched: Cochrane library, PubMed, EMBASE, PsycInfo and CINAHL, alongside preprints. Identified literature were assessed by two reviewers for inclusion. A narrative summary was used to interpret the tabulated results.
RESULTS
Diagnostic performances were reported as specificities, sensitivities, and AUC. The AUC for S. haematobium recombinant antigens ranged from 0.65 to 0.98, and 0.69 to 0.96 for urine IgG ELISA. S. mansoni recombinant antigens had sensitivities ranging from 65.3% to 100% and specificities ranging from 57.4% to 100%. Except for 4 peptides which had poor diagnostic performances, most peptides had sensitivities ranging from 67.71% to 96.15% and specificities ranging from 69.23% to 100%. S. mansoni chimeric protein was reported to have a sensitivity of 86.8% and a specificity of 94.2%.
CONCLUSION
The tetraspanin CD63 antigen had the best diagnostic performance for S. haematobium. The tetraspanin CD63 antigen Serum IgG POC-ICTs had a sensitivity of 89% and a specificity of 100%. Peptide Smp_150390.1 (216-230) serum based IgG ELISA had the best diagnostic performance for S. mansoni with a sensitivity of 96.15% and a specificity of 100%. Peptides were reported to demonstrate good to excellent diagnostic performances. S. mansoni multi-peptide chimeric protein further improved the diagnostic accuracy of synthetic peptides. Together with the advantages associated with urine sampling technique, we recommend development of multi-peptide chimeric proteins urine based point of care tools.
Identifiants
pubmed: 36862712
doi: 10.1371/journal.pone.0282233
pii: PONE-D-22-25115
pmc: PMC9980832
doi:
Substances chimiques
Tetraspanin 30
0
Peptides
0
Blood Group Antigens
0
Recombinant Proteins
0
Recombinant Fusion Proteins
0
Immunoglobulin G
0
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0282233Informations de copyright
Copyright: © 2023 Vengesai et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Mol Cell Probes. 2017 Feb;31:2-21
pubmed: 27986555
Proteomics Clin Appl. 2010 May;4(5):499-510
pubmed: 21137067
Acta Trop. 2021 Mar;215:105800
pubmed: 33352167
PLoS Negl Trop Dis. 2022 Jan 24;16(1):e0010151
pubmed: 35073344
BMJ Open. 2017 May 29;7(5):e015435
pubmed: 28554932
PLoS Negl Trop Dis. 2010 Jul 20;4(7):e754
pubmed: 20651931
Biotechnol Prog. 2017 May;33(3):804-814
pubmed: 28371522
Parasitology. 2020 Jul;147(8):873-888
pubmed: 31831084
Open Forum Infect Dis. 2021 Jan 28;8(3):ofab043
pubmed: 33723509
Cochrane Database Syst Rev. 2015 Mar 11;(3):CD009579
pubmed: 25758180
PLoS One. 2017 Aug 17;12(8):e0182299
pubmed: 28817585
PLoS Negl Trop Dis. 2017 Jun 5;11(6):e0005593
pubmed: 28582412
Mem Inst Oswaldo Cruz. 2006 Sep;101 Suppl 1:355-7
pubmed: 17308797
Am J Trop Med Hyg. 2022 Mar 28;:
pubmed: 35344927
Biotechnol J. 2020 Sep;15(9):e2000069
pubmed: 32463974
Parasitology. 2018 Sep;145(11):1355-1366
pubmed: 29506583
Parasitol Res. 2009 Oct;105(5):1435-44
pubmed: 19639340
Trans R Soc Trop Med Hyg. 2009 Jan;103(1):45-51
pubmed: 18951599
J Infect Dis. 2016 Oct 15;214(8):1225-34
pubmed: 27190177
Trends Parasitol. 2004 Jan;20(1):35-9
pubmed: 14700588
Nucleic Acids Res. 2021 Jan 8;49(D1):D344-D354
pubmed: 33156333
Parasitol Int. 2005 Mar;54(1):69-74
pubmed: 15710554
BMJ Open. 2021 Sep 14;11(9):e049883
pubmed: 34521668
PLoS Negl Trop Dis. 2015 May 14;9(5):e0003752
pubmed: 25973845
Biochim Biophys Acta. 2001 Sep 3;1514(1):14-20
pubmed: 11513801
Acta Trop. 2005 Nov-Dec;96(2-3):130-6
pubmed: 16143288
Acta Trop. 2020 Apr;204:105356
pubmed: 32001249
Acta Trop. 2018 Jun;182:264-270
pubmed: 29526480
PLoS Negl Trop Dis. 2022 Jun 21;16(6):e0010138
pubmed: 35727821
PLoS Negl Trop Dis. 2015 Aug 20;9(8):e0004021
pubmed: 26291988
Parasitol Res. 2016 Aug;115(8):2981-94
pubmed: 27083187
PLoS Negl Trop Dis. 2021 Mar 25;15(3):e0009191
pubmed: 33764979
BMJ Open. 2021 Jul 30;11(7):e042279
pubmed: 34330850
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
PLoS Negl Trop Dis. 2019 Mar 14;13(3):e0006974
pubmed: 30870412
Front Immunol. 2018 Nov 14;9:2635
pubmed: 30487796
BMC Infect Dis. 2020 Oct 29;20(1):803
pubmed: 33121458
Vet Parasitol. 2005 Jul 15;131(1-2):53-60
pubmed: 15946799
Mol Biochem Parasitol. 2019 Dec;234:111231
pubmed: 31628972
PLoS Negl Trop Dis. 2010 Aug 03;4(8):e771
pubmed: 20689813
Appl Immunohistochem Mol Morphol. 2014 Apr;22(4):241-52
pubmed: 24714041
Immunol Lett. 2003 Sep 8;88(3):211-9
pubmed: 12941480
Parasitol Int. 2003 Dec;52(4):269-79
pubmed: 14665383
PLoS Negl Trop Dis. 2011 Oct;5(10):e1368
pubmed: 22039561
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Parasit Vectors. 2011 Sep 29;4:190
pubmed: 21958506
Clin Microbiol Infect. 2017 May;23(5):335.e1-335.e5
pubmed: 28259548
PLoS Negl Trop Dis. 2022 Jul 11;16(7):e0010619
pubmed: 35816547
Mem Inst Oswaldo Cruz. 2002;97 Suppl 1:167-9
pubmed: 12426614
Int J Infect Dis. 2008 Nov;12(6):e39-47
pubmed: 18571965
Parasitol Int. 2021 Aug;83:102346
pubmed: 33857597
Cell Mol Immunol. 2021 Mar;18(3):621-631
pubmed: 33483707
Vaccines (Basel). 2021 Apr 01;9(4):
pubmed: 33915716
Am J Trop Med Hyg. 2013 Jun;88(6):1028-31
pubmed: 23530072
Lancet Microbe. 2021 Nov;2(11):e617-e626
pubmed: 34977830
Travel Med Infect Dis. 2021 May-Jun;41:102035
pubmed: 33775915
Am J Trop Med Hyg. 2021 Nov 08;106(1):303-311
pubmed: 34749308
Immunobiology. 2011 Mar;216(3):379-85
pubmed: 20691496
Trans R Soc Trop Med Hyg. 2008 Apr;102(4):360-6
pubmed: 18314149
Nutrients. 2021 Nov 12;13(11):
pubmed: 34836311
PLoS One. 2022 Jan 25;17(1):e0248666
pubmed: 35077448
Int J Parasitol. 2014 Oct 1;44(11):765-74
pubmed: 24992655
Curr Protein Pept Sci. 2003 Aug;4(4):299-308
pubmed: 14529537